- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome ; volume:10 ; number:1 ; day:10 ; month:4 ; year:2018 ; pages:1-5 ; date:12.2018
Alzheimer's research & therapy ; 10, Heft 1 (10.4.2018), 1-5, 12.2018
- Contributor
-
Strydom, Andre
Heslegrave, Amanda
Startin, Carla M.
Mok, Kin Y.
Hardy, John
Groet, Jurgen
Nizetic, Dean
Zetterberg, Henrik
SpringerLink (Online service)
- DOI
-
10.1186/s13195-018-0367-x
- URN
-
urn:nbn:de:101:1-2018061519182370611814
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Strydom, Andre
- Heslegrave, Amanda
- Startin, Carla M.
- Mok, Kin Y.
- Hardy, John
- Groet, Jurgen
- Nizetic, Dean
- Zetterberg, Henrik
- SpringerLink (Online service)
Other Objects (12)
Neurofilament light chain as neuronal injury marker – what is needed to facilitate implementation in clinical laboratory practice?
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer’s disease
Blood-based biomarkers in Alzheimer’s disease – moving towards a new era of diagnostics
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Blood-based molecular biomarkers for Alzheimer’s disease
Circulating levels of neurofilament light chain as a biomarker of infarct and white matter hyperintensity volumes after ischemic stroke
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease
Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration
Neurofilament light chain as neuronal injury marker – what is needed to facilitate implementation in clinical laboratory practice?
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer’s disease
Blood-based biomarkers in Alzheimer’s disease – moving towards a new era of diagnostics
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Blood-based molecular biomarkers for Alzheimer’s disease
Circulating levels of neurofilament light chain as a biomarker of infarct and white matter hyperintensity volumes after ischemic stroke
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease
Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration
Neurofilament light chain as neuronal injury marker – what is needed to facilitate implementation in clinical laboratory practice?
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer’s disease
Blood-based biomarkers in Alzheimer’s disease – moving towards a new era of diagnostics
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Blood-based molecular biomarkers for Alzheimer’s disease
Circulating levels of neurofilament light chain as a biomarker of infarct and white matter hyperintensity volumes after ischemic stroke
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease